Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:22 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 114,498 2.500% | -86,971 (-43.17%) | Filing History |
| 2021-02-16 08:57 am Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Alta Partners VIII L.P. | 0 0.000% | -194,852 (Position Closed) | Filing History |
| 2021-02-12 5:23 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital, LLC | 9,342 0.200% | -223,508 (-95.99%) | Filing History |
| 2021-02-12 4:25 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 185,416 4.100% | -51,423 (-21.71%) | Filing History |
| 2021-02-12 4:10 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 237,098 5.300% | 112,608 (+90.46%) | Filing History |